Browsing Wolfson Institute of Preventive Medicine by Author "Tutt, A"
Now showing items 1-5 of 5
-
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (vol 28, pg 1700, 2017)
Curigliano, G; Burstein, HJ; Winer, EP; Gnant, M; Dubsky, P; Loibl, S; Colleoni, M; Regan, MM; Piccart-Gebhart, M; Senn, H-J (2019-07) -
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (vol 28, pg 1700, 2017)
Curigliano, G; Burstein, HJ; Winer, EP; Gnant, M; Dubsky, P; Loibl, S; Colleoni, M; Regan, MM; Piccart-Gebhart, M; Senn, H-J (2018-10) -
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.
Curigliano, G; Burstein, HJ; P Winer, E; Gnant, M; Dubsky, P; Loibl, S; Colleoni, M; Regan, MM; Piccart-Gebhart, M; Senn, H-J (2017-08-01)The 15th St. Gallen International Breast Cancer Conference 2017 in Vienna, Austria reviewed substantial new evidence on loco-regional and systemic therapies for early breast cancer. Treatments were assessed in light of ... -
Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al.
Dubsky, P; Curigliano, G; Burstein, HJ; Winer, EP; Gnant, M; Loibl, S; Colleoni, M; Regan, MM; Piccart-Gebhart, M; Senn, H-J (2018-01) -
Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials
Bergh, J; Pritchard, KI; Swain, S; Cameron, D; Albain, K; Anderson, S; Arriagada, R; Bartlett, J; Bergsten-Nordstrom, E; Bliss, J (2021-08)